Hypothalamic BDNF-mTOR signaling promotes hypertension by increasing cardiovascular sensitivity to stress
下丘脑 BDNF-mTOR 信号通过增加心血管对压力的敏感性促进高血压
基本信息
- 批准号:10736248
- 负责人:
- 金额:$ 60.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-21 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAntihypertensive AgentsBlood PressureBlood VesselsBlood flowBrainBrain regionBrain-Derived Neurotrophic FactorCOVID-19CardiacCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCharacteristicsChronicChronic stressComplexConsciousDataDevelopmentElectrophysiology (science)EquilibriumFRAP1 geneFemaleFutureGlutamatesGoalsHypertensionHypothalamic structureImmunofluorescence ImmunologicIn VitroIndividualLifeMeasuresMediatingMetabolicModelingModernizationMonitorMorphologyNeuronal PlasticityNeuronsNeurosecretory SystemsOrganOrganismOutputPathway interactionsPhysiologicalPlayPredispositionPsychological StressPublic HealthRattusRegulationResearchRiskRisk FactorsRoleSignal TransductionSliceSocial isolationSocietiesSocioeconomic StatusSpinalStimulusStressSympathetic Nervous SystemSynapsesSynaptic TransmissionTechniquesTelemetryTestingVertebral columnViral VectorWorkacute stressbiological adaptation to stressblood pressure elevationblood pressure reductioncardiovascular healthcardiovascular risk factorclinically relevantcopingdensityexperimental studygenetic manipulationhypertensivein vivomalemultidisciplinaryneural circuitneuronal cell bodyneuronal circuitryneuronal excitabilityneurotransmissionnew therapeutic targetnormotensivenovelparaventricular nucleuspatch clamppreventpsychologicpsychological stressorrenal damageresponsesensorstressortherapeutic targettransmission process
项目摘要
Chronic psychological stressors, including work-related stress, poor socioeconomic status and social isolation —
all heightened by recent Covid-19 lockdowns — are major risk factors for hypertension and cardiovascular
disease. Stress-activated regulatory mechanisms that stimulate the sympathetic nervous system to elevate blood
pressure and redistribute blood flow to vital organs have evolved as life-protecting measures. From an
evolutionary perspective, enhancing cardiovascular responses through long-term sensitization of these
mechanisms is advantageous to organisms subjected to repeated stressors. However, in modern society, where
coping with stressful situations rarely requires marked elevations in blood pressure, these actions become
detrimental, as repeated unnecessary overload of the cardiovascular system exerts irreversible cardiac, vascular,
and renal damage. Accordingly, augmented cardiovascular sensitivity to stressors in young, normotensive
individuals is strongly correlated with the risk of becoming hypertensive later in life. Our long-term goal is to
investigate the central mechanisms that determine the magnitude of blood pressure elevations elicited by stress
in order to identify novel anti-hypertensive therapeutic targets. Here, we propose to investigate a novel signaling
cascade mediated by brain-derived neurotrophic factor (BDNF) and mechanistic target of rapamycin (mTOR) in
the paraventricular nucleus of the hypothalamus (PVN), a brain region that plays a key role in orchestrating
neuroendocrine and cardiovascular stress responses. BDNF expression is upregulated in the PVN during stress
in response to increased excitatory input and neuronal activity. We have previously shown that BDNF elicits
important adaptive changes within the PVN to elevate sympathetic activity and blood pressure. Our preliminary
data suggest that BDNF stimulates mTOR, as part of mTOR complex-1 (mTORC1) in PVN neurons, and mTORC1
can fundamentally change neuronal morphology and synaptic connectivity, resulting in elevated neuronal
excitability to augment cardiovascular stress responses and promote hypertension. To test our hypothesis, we
employ a comprehensive array of in vitro patch-clamp studies, neuronal morphology analysis, as well as in vivo
experiments using viral vector-mediated genetic manipulation of BDNF and mTORC1 and telemetric monitoring
of cardiovascular parameters in rats. In Aim 1, we test whether mTORC1 activation in the PVN elevates blood
pressure, augments cardiovascular stress responses, and mediates hypertensive actions of BDNF. In Aim 2, we
determine whether BDNF–mTORC1 signaling regulates structural and functional characteristics of PVN pre-
sympathetic neurons, resulting in enhanced excitability. In Aim 3, we test whether inhibition of BDNF–mTORC1
prevents chronic stress-induced hypertension in borderline hypertensive rats. These studies have the potential
to significantly advance the field by establishing the BDNF–mTORC1 axis as a highly important regulator of
autonomic and cardiovascular function that determines the amplitude of blood pressure elevations during stress
and elicits long-term adaptive mechanisms in the PVN that promote the development of hypertension.
慢性心理压力源,包括与工作相关的压力、不良的社会经济地位和社会孤立——
最近 Covid-19 封锁导致的所有哮喘都是高血压和心血管疾病的主要危险因素
压力激活的调节机制刺激交感神经系统升高血液。
压力和重新分配重要器官的血流已发展成为生命保护措施。
从进化的角度来看,通过对这些物质的长期敏化来增强心血管反应
机制有利于遭受反复应激的生物体。然而,在现代社会中。
应对压力情况很少需要显着升高血压,这些行为变得
疼痛,因为心血管系统反复不必要地超负荷,对心脏、血管、
因此,血压正常的年轻人的心血管对压力源的敏感性增强。
个体与晚年患高血压的风险密切相关。我们的长期目标是
研究决定压力引起的血压升高程度的中心机制
为了确定新的抗高血压治疗靶点,我们建议研究一种新的信号传导。
脑源性神经营养因子(BDNF)和雷帕霉素(mTOR)机制靶点介导的级联反应
下丘脑室旁核(PVN),一个在协调中发挥关键作用的大脑区域
神经内分泌和心血管应激反应期间 PVN 中 BDNF 表达上调。
我们之前已经证明 BDNF 会引起兴奋性输入和神经活动的增加。
我们的初步研究表明,PVN 内的重要适应性变化可提高交感神经活动和血压。
数据表明 BDNF 刺激 mTOR,作为 PVN 神经元中 mTOR 复合物 1 (mTORC1) 的一部分,并且 mTORC1
可以从根本上改变神经元形态和突触连接,导致神经元
兴奋性会增强心血管应激反应并促进高血压。为了检验我们的假设,我们。
采用一系列全面的体外膜片钳研究、神经形态分析以及体内
使用病毒载体介导的 BDNF 和 mTORC1 基因操作以及遥测监测进行实验
在目标 1 中,我们测试了 PVN 中的 mTORC1 激活是否会升高血液水平。
压力,增强心血管应激反应,并介导 BDNF 的高血压作用。
确定 BDNF-mTORC1 信号传导是否调节 PVN 前体的结构和功能特征
交感神经元,导致兴奋性增强。在目标 3 中,我们测试是否抑制 BDNF-mTORC1。
预防边缘性高血压大鼠的慢性应激性高血压。这些研究具有潜力。
通过将 BDNF-mTORC1 轴建立为非常重要的调节因子,显着推进该领域的发展
自主神经和心血管功能决定压力期间血压升高的幅度
并在 PVN 中引发长期适应机制,促进高血压的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benedek Erdos其他文献
Benedek Erdos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benedek Erdos', 18)}}的其他基金
A novel experimental model of chronic stress and hypertension for studying dementia-related neurovascular dysfunction in the hippocampus
用于研究海马痴呆相关神经血管功能障碍的新型慢性应激和高血压实验模型
- 批准号:
10194742 - 财政年份:2021
- 资助金额:
$ 60.27万 - 项目类别:
A novel experimental model of chronic stress and hypertension for studying dementia-related neurovascular dysfunction in the hippocampus
用于研究海马痴呆相关神经血管功能障碍的新型慢性应激和高血压实验模型
- 批准号:
10400211 - 财政年份:2021
- 资助金额:
$ 60.27万 - 项目类别:
Brain-derived neurotrophic factor: a novel regulator of cardiovascular function in the hypothalamus
脑源性神经营养因子:下丘脑心血管功能的新型调节剂
- 批准号:
9903424 - 财政年份:2017
- 资助金额:
$ 60.27万 - 项目类别:
相似国自然基金
以辣椒素受体为靶点,寻找新作用机制的抗高血压药研究
- 批准号:30430740
- 批准年份:2004
- 资助金额:140.0 万元
- 项目类别:重点项目
哌嗪类抗高血压药物的研究
- 批准号:39560085
- 批准年份:1995
- 资助金额:7.5 万元
- 项目类别:地区科学基金项目
苯骈吡喃类钾通道启开剂的合成及其心血管活性
- 批准号:39370811
- 批准年份:1993
- 资助金额:6.0 万元
- 项目类别:面上项目
相似海外基金
Angiotensin-(1-7) engages hypothalamic arcuate-paraventricular nucleus inhibitory pathways to lower blood pressure
血管紧张素-(1-7) 参与下丘脑弓状室旁核抑制通路来降低血压
- 批准号:
10751682 - 财政年份:2023
- 资助金额:
$ 60.27万 - 项目类别:
Novel Pharmacological Treatment for Preeclampsia
先兆子痫的新型药物治疗
- 批准号:
10758980 - 财政年份:2023
- 资助金额:
$ 60.27万 - 项目类别:
Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKD
利尿剂与 CKD 细胞外容量、利尿钠肽、症状和心血管结局变化的关系
- 批准号:
10595584 - 财政年份:2022
- 资助金额:
$ 60.27万 - 项目类别:
A novel paradigm of sensitization of the tumor microenvironment with image-guided ultrasound cavitation and mechanotherapeutics for targeted HCC treatment
通过图像引导超声空化和机械治疗对肿瘤微环境进行敏化的新范例,用于靶向 HCC 治疗
- 批准号:
10516814 - 财政年份:2022
- 资助金额:
$ 60.27万 - 项目类别:
Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKD
利尿剂与 CKD 细胞外容量、利尿钠肽、症状和心血管结局变化的关系
- 批准号:
10366684 - 财政年份:2022
- 资助金额:
$ 60.27万 - 项目类别: